Mairs & Power Discusses Zoetis' Long-Term Growth Outlook in 2025 Q4 Letter

In its fourth-quarter 2025 investor letter, Mairs & Power, a registered investment advisor, outlined its perspective on Zoetis Inc. (ZTS) as a long-term growth opportunity for the Mairs & Power Growth Fund. The letter, which is available for download, does not include new financial data or specific performance figures for the company but focuses on strategic positioning and market dynamics.\n\nThe firm emphasized Zoetis' role in the healthcare sector, particularly in veterinary medicine, and its potential to benefit from ongoing trends in animal health and wellness. While no concrete financial projections or market share figures were provided, the letter suggests confidence in the company's ability to adapt to evolving industry demands.\n\nInvestors seeking quantitative metrics may find the letter lacking in hard data, but the qualitative analysis underscores Zoetis' position as a key player in a growing market segment. The absence of specific numbers reflects the letter's broader focus on long-term strategic considerations rather than short-term financial performance.\n\nMairs & Power's commentary aligns with broader industry discussions about the resilience of healthcare-related sectors amid macroeconomic uncertainty. Zoetis' operations, which span multiple geographies and product lines, are positioned to capitalize on sustained demand for animal health solutions.\n\nFor stakeholders in the Mairs & Power Growth Fund, the letter serves as a strategic overview rather than a detailed financial report. The firm's approach highlights the importance of long-term vision in navigating market volatility and sector-specific challenges.